powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1043534514
Anna Mclean
MD
Pulmonary Disease
Washington,
DC
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (1)
CCN 092002
Long-term care hospital
QUALITY · MIPS · 2024
Final MIPS score
86.5
Quality
77.2
Cost
63.4
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.48%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$101
Payment records
2
By payment type
Food and Beverage
$101
Top paying entities
Food and Beverage
$101
PRESCRIBING · PART D · 2024
Total Rx claims
41
Beneficiaries
—
Total drug cost
$2K
Distinct drugs
1
Brand share
0.0%
Top prescribed drugs
Glycopyrrolate
41 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
308
Unique beneficiaries
—
Total services
1,961
Distinct HCPCS
6
Medicare payment
$201K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 50 Pulmonary Disease providers in DC — top quintile (cohort median 585).
